Interstitial Lung Disease, Pulmonary Hypertension
Conditions
Brief summary
Pulmonary hypertension (PH) is a common disorder among patients with interstitial lung disease (ILD). The symptoms are usually nonspecific and overlooked. Thus, a noninvasive screening modality is recommended for early detection of PH because of its potentially significant impact on treatment strategy and clinical outcomes. Objectives: To evaluate the usefulness of assessing forced vital capacity (FVC%), diffusion capacity of the lung for carbon monoxide (DLCO%), and FVC%/DLCO% ratio to predict pulmonary hypertension among patients with ILDs.
Interventions
DIAGNOSTIC_TESTPulmonary function test
forced vital capacity and diffusing capacity
Sponsors
Assiut University
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* This retrospective study included all patients diagnosed with interstitial lung disease (ILD) who were followed up by the chest department of a tertiary hospital between September 2016 and January 2017
Exclusion criteria
* patients with occupational history * collagen vascular disease predisposing them to lung disorders * patients who could not undergo pulmonary function testing
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| value of FVC/DLCO in predicting PAH in IPF | 6 months | To evaluate the usefulness of assessing forced vital capacity (FVC%), diffusion capacity of the lung for carbon monoxide (DLCO%), and FVC%/DLCO% ratio to predict pulmonary hypertension among patients with ILDs |
Countries
Egypt
Outcome results
None listed